
đ§ŹHow One Leader United 120 Experts to Transform Cancer Care | Samir Khleif (Part 3/4)
"I always kept my lab at NCI, so I was always doing my research. But I was asked by him to lead the oncology critical path at the FDA, and I did that. I was doing that while also helping the King of Jordan develop the biotechnology strategy of Jordan and what it would take to move it forward." In this episode of The Biotech Startups Podcast, Samir Khleif shares pivotal moments from his career at the crossroads of government, research, and entrepreneurshipâreflecting on being chosen by FDA commissioner Andy von Eschenbach to lead oncology reform at the FDA, while simultaneously running his NCI research lab and advising Jordanâs national biotech strategy. He highlights the power of academic freedom, assembling a task force of over 120 top experts to advance regulatory change, and the leadership lessons gained building world-class teamsâall culminating in a breakthrough that sparked the founding of Georgiamune.
The Biotech Startups Podcast · Excedr
Audio is streamed directly from the publisher (media.fame.so) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
"I always kept my lab at NCI, so I was always doing my research. But I was asked by him to lead the oncology critical path at the FDA, and I did that. I was doing that while also helping the King of Jordan develop the biotechnology strategy of Jordan and what it would take to move it forward."
- Leading National Reform: Spearheading FDA oncology reform with 120+ experts.
- Balancing Multiple Roles: Navigating government, research, and global biotech.
- The Value of Academic Freedom: Leveraging flexibility to drive innovation.
- Building Top-Performing Teams: Attracting and motivating elite talent.
- From Breakthrough to Startup: Turning discovery into Georgiamune.
Timestamps: